News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
346,821 Results
Type
Article (21208)
Company Profile (146)
Press Release (325453)
Multimedia
Podcasts (113)
Webinars (17)
Section
Business (106165)
Career Advice (925)
Deals (18722)
Drug Delivery (110)
Drug Development (51098)
Employer Resources (80)
FDA (7864)
Job Trends (7847)
News (187352)
Policy (17525)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (751)
Accelerated approval (19)
Adcomms (23)
Allergies (82)
Alliances (28022)
ALS (91)
Alzheimer's disease (793)
Antibody-drug conjugate (ADC) (207)
Approvals (8045)
Artificial intelligence (281)
Autoimmune disease (79)
Automation (15)
Bankruptcy (178)
Best Places to Work (5573)
BIOSECURE Act (14)
Biosimilars (170)
Biotechnology (65)
Bladder cancer (74)
Brain cancer (35)
Breast cancer (264)
Cancer (2313)
Cardiovascular disease (240)
Career advice (771)
Career pathing (24)
CAR-T (110)
CDC (14)
Cell therapy (289)
Cervical cancer (11)
Clinical research (44841)
Collaboration (1009)
Company closure (1)
Compensation (372)
Complete response letters (52)
COVID-19 (1161)
CRISPR (49)
C-suite (535)
Cystic fibrosis (88)
Data (3298)
Decentralized trials (2)
Denatured (28)
Depression (84)
Diabetes (250)
Diagnostics (1902)
Digital health (15)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (171)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (137)
Earnings (40936)
Editorial (46)
Employer branding (10)
Employer resources (78)
Events (51059)
Executive appointments (621)
FDA (9449)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (652)
Gene editing (90)
Generative AI (31)
Gene therapy (269)
GLP-1 (824)
Government (2030)
Grass and pollen (4)
Guidances (207)
Healthcare (5976)
HIV (28)
Huntington's disease (24)
IgA nephropathy (60)
Immunology and inflammation (168)
Immuno-oncology (35)
Indications (69)
Infectious disease (1294)
Inflammatory bowel disease (118)
Inflation Reduction Act (12)
Influenza (46)
Intellectual property (136)
Interviews (123)
IPO (7435)
IRA (53)
Job creations (2446)
Job search strategy (680)
JPM (52)
Kidney cancer (10)
Labor market (61)
Layoffs (343)
Leadership (27)
Legal (4164)
Liver cancer (37)
Longevity (8)
Lung cancer (333)
Lymphoma (207)
Machine learning (21)
Management (31)
Manufacturing (529)
MASH (104)
Medical device (2030)
Medtech (2038)
Mergers & acquisitions (11814)
Metabolic disorders (883)
Multiple sclerosis (98)
NASH (20)
Neurodegenerative disease (160)
Neuropsychiatric disorders (72)
Neuroscience (1518)
Neurotech (1)
NextGen: Class of 2026 (2398)
Non-profit (951)
Now hiring (46)
Obesity (514)
Opinion (232)
Ovarian cancer (66)
Pain (146)
Pancreatic cancer (95)
Parkinson's disease (155)
Partnered (18)
Patents (278)
Patient recruitment (243)
Peanut (19)
People (34581)
Pharmaceutical (76)
Pharmacy benefit managers (33)
Phase 1 (14127)
Phase 2 (18916)
Phase 3 (15206)
Pipeline (2877)
Policy (235)
Postmarket research (1619)
Preclinical (4938)
Press Release (29)
Prostate cancer (131)
Psychedelics (27)
Radiopharmaceuticals (181)
Rare diseases (524)
Real estate (3225)
Recruiting (33)
Regulatory (13800)
Reports (25)
Research institute (843)
Resumes & cover letters (143)
Rett syndrome (7)
RNA editing (12)
RSV (43)
Schizophrenia (118)
Series A (119)
Series B (82)
Service/supplier (7)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2049)
State (2)
Stomach cancer (12)
Supply chain (76)
Tariffs (94)
The Weekly (83)
Vaccines (424)
Venture capital (68)
Weight loss (376)
Women's health (42)
Worklife (9)
Date
Today (2)
Last 7 days (297)
Last 30 days (1126)
Last 365 days (15310)
2026 (1467)
2025 (15521)
2024 (17735)
2023 (19686)
2022 (25926)
2021 (26703)
2020 (24982)
2019 (20202)
2018 (15696)
2017 (17289)
2016 (16264)
2015 (18855)
2014 (14822)
2013 (12581)
2012 (13522)
2011 (13866)
2010 (12756)
Location
Africa (429)
Alabama (41)
Alaska (1)
Arizona (92)
Arkansas (8)
Asia (25974)
Australia (3349)
California (4799)
Canada (1819)
China (745)
Colorado (197)
Connecticut (195)
Delaware (180)
Europe (53637)
Florida (831)
Georgia (98)
Hawaii (2)
Idaho (18)
Illinois (444)
India (52)
Indiana (295)
Iowa (5)
Japan (321)
Kansas (83)
Kentucky (29)
Louisiana (7)
Maine (4)
Maryland (597)
Massachusetts (3852)
Michigan (68)
Minnesota (241)
Mississippi (3)
Missouri (44)
Montana (12)
Nebraska (14)
Nevada (35)
New Hampshire (11)
New Jersey (1852)
New Mexico (21)
New York (1316)
North Carolina (800)
North Dakota (3)
Northern California (2242)
Ohio (130)
Oklahoma (8)
Oregon (24)
Pennsylvania (1061)
Puerto Rico (19)
Rhode Island (27)
South America (626)
South Carolina (12)
Southern California (2030)
Tennessee (64)
Texas (654)
United States (18174)
Utah (95)
Virginia (178)
Washington D.C. (60)
Washington State (375)
West Virginia (1)
Wisconsin (49)
Wyoming (1)
346,821 Results for "circle pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
November 3, 2025
·
2 min read
Press Releases
Circle Pharma Appoints Anne E. Borgman, M.D., as Chief Medical Officer
December 2, 2025
·
3 min read
Press Releases
Circle Pharma Announces Participation in Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Circle Pharma Announces Nomination of CID-165, an Oral First-in-class Cyclin D1 RxL Inhibitor, as Development Candidate for its Second Oncology Program
December 18, 2025
·
2 min read
Press Releases
Circle Pharma to Participate in Upcoming September 2025 Investor Conferences
September 3, 2025
·
1 min read
Press Releases
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 24, 2025
·
3 min read
Press Releases
Circle Pharma Announces Agreement with Lilly to Further Enhance AI/ML Capabilities and Accelerate Development of New Oral Macrocycle Therapies
September 9, 2025
·
3 min read
Press Releases
Circle Pharma Announces Upcoming Poster Presentation Highlighting the Anti-tumor Potential of Cyclin D1 RxL Inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 15, 2025
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
1 of 34,683
Next
